MedKoo Cat#: 100384 | Name: Fotemustine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Fotemustine is a chloroethylating nitrosourea with antineoplastic activity. Fotemustine alkylates guanine by forming chloroethyl adducts at the 6 position of guanine, resulting in N1-guanine and N3-cytosine cross linkages, inhibition of DNA synthesis, cell cycle arrest, and finally apoptosis. This agent is lipophilic and crosses the blood-brain barrier. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus).

Chemical Structure

Fotemustine
Fotemustine
CAS#92118-27-9

Theoretical Analysis

MedKoo Cat#: 100384

Name: Fotemustine

CAS#: 92118-27-9

Chemical Formula: C9H19ClN3O5P

Exact Mass: 315.0751

Molecular Weight: 315.69

Elemental Analysis: C, 34.24; H, 6.07; Cl, 11.23; N, 13.31; O, 25.34; P, 9.81

Price and Availability

Size Price Availability Quantity
50mg USD 600.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Fotemustine; Muphoran; Mustophorane; Mustoforan; Fotemustinum; S 10036; S10036; S-10036
IUPAC/Chemical Name
diethyl (1-(3-(2-chloroethyl)-3-nitrosoureido)ethyl)phosphonate
InChi Key
YAKWPXVTIGTRJH-UHFFFAOYSA-N
InChi Code
InChI=1S/C9H19ClN3O5P/c1-4-17-19(16,18-5-2)8(3)11-9(14)13(12-15)7-6-10/h8H,4-7H2,1-3H3,(H,11,14)
SMILES Code
CC(P(OCC)(OCC)=O)NC(N(CCCl)N=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Fotemustine is a nitrosourea alkylating agent approved for use in the treatment of metastasising melanoma. A study has shown that fotemustine produces improved response rates and but does not increase survival (over dacarbazine in the treatment of disseminated cutaneous melanoma. Median survival was 7.3 months with fotemustine versus 5.6 months with DTIC (P=.067). There was also toxicity prevalence in fotemustine arm. The main toxicity was grade 3 to 4 neutropenia (51% with fotemustine v 5% with DTIC) and thrombocytopenia (43% v 6%, respectively). (source: http://en.wikipedia.org/wiki/Fotemustine).          

Preparing Stock Solutions

The following data is based on the product molecular weight 315.69 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL